Patents Assigned to Protherics Inc.
  • Antivenom immunesera
    Patent number: 6833131
    Abstract: An antivenom comprising a mixture of monospecific antisera each raised against venoms of one species or sub-species is disclosed. Also disclosed is a pharmaceutical composition comprising the antivenom of the invention, and a method of treating envenomation in a mammal comprising administering the claimed antivenom.
    Type: Grant
    Filed: August 5, 1994
    Date of Patent: December 21, 2004
    Assignee: Protherics Inc.
    Inventor: Damon Charles Smith
  • Antibody fragments in therapy
    Patent number: 6193969
    Abstract: A method of neutralizing TNF&agr; in a patient benefiting from such neutralizing, comprising administering to the patient IgG Fab fragment reactive towards TNF&agr;. Suitably, the patient is suffering from septic shock or from the symptoms of septic shock. It is preferred if the Fab fragment is derived from polyclonal IgG.
    Type: Grant
    Filed: March 10, 1995
    Date of Patent: February 27, 2001
    Assignee: Protherics Inc.
    Inventor: John Landon